Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ADMA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Adam S. Grossman Director, Officer | ADMA ADMA Biologics Inc | 189,000 | $2.0M | 10b5-1 | Nov 5, 2026 | Form 4 ↗ same day · 147,000 shares | Form 144 ↗ |
| Mar 10, 2026 | Brad L. Tade Former Officer | ADMA ADMA Biologics Inc | 50,026 | $790.9K | — | Mar 10, 2026 | — | Form 144 ↗ |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina Officer | ADMA ADMA Biologics Inc | 10,096 | $155.4K | — | Mar 9, 2026 | Form 4 ↗ 1 day later · 10,096 shares | Form 144 ↗ |
| Feb 17, 2026 | Adam S. Grossman Director, Officer | ADMA ADMA Biologics Inc | 125,000 | $2.0M | — | Feb 17, 2026 | Form 4 ↗ same day · 21,000 shares | Form 144 ↗ |
| Feb 17, 2026 | Adam S. Grossman Director, Officer | ADMA ADMA Biologics Inc | 84,000 | $1.4M | — | Feb 17, 2026 | Form 4 ↗ same day · 21,000 shares | Form 144 ↗ |
| Oct 24, 2025 | Adam S. Grossman Director and Officer | ADMA ADMA Biologics Inc | 63,000 | $960.8K | — | Oct 24, 2025 | Form 4 ↗ same day · 21,000 shares | Form 144 ↗ |
| Jul 15, 2025 | Adam S. Grossman Director and Officer | ADMA ADMA Biologics Inc | 63,000 | $1.2M | — | Jul 15, 2025 | Form 4 ↗ 1 day later · 21,000 shares | Form 144 ↗ |
| Jun 12, 2025 | Steve Elms Director | ADMA ADMA Biologics Inc | 425,621 | $9.3M | — | Jun 12, 2025 | Form 4 ↗ 4 days later · 425,621 shares | Form 144 ↗ |
| Jun 9, 2025 | Jerrold B. Grossman Director | ADMA ADMA Biologics Inc | 10,000 | $206.1K | — | Jun 9, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Jun 4, 2025 | Lawrence P Guiheen Rev Tr DTD 09/20/19 Director | ADMA ADMA Biologics Inc | 20,000 | $415.0K | — | Jun 4, 2025 | Form 4 ↗ 7 days later · 20,000 shares | Form 144 ↗ |
| May 21, 2025 | Lawrence P. Guiheen Director | ADMA ADMA Biologics Inc | 20,000 | $388.8K | — | May 30, 2025 | Form 4 ↗ 2 days later · 9,000 shares | Form 144 ↗ |
| May 21, 2025 | Lawrence P. Guiheen Director | ADMA ADMA Biologics Inc | 9,000 | $184.0K | — | May 21, 2025 | Form 4 ↗ 2 days later · 9,000 shares | Form 144 ↗ |
| Mar 19, 2025 | Adam S. Grossman Director and Officer | ADMA ADMA Biologics Inc | 84,000 | $1.6M | — | Mar 19, 2025 | Form 4 ↗ 2 days later · 21,000 shares | Form 144 ↗ |
| Nov 22, 2024 | Adam S. Grossman Director and Officer | ADMA ADMA Biologics Inc | 48,967 | $1.0M | — | Nov 22, 2024 | Form 4 ↗ same day · 48,967 shares | Form 144 ↗ |
| Nov 22, 2024 | Brad L. Tade Officer | ADMA ADMA Biologics Inc | 15,000 | $319.5K | — | Nov 22, 2024 | Form 4 ↗ same day · 15,000 shares | Form 144 ↗ |
| Sep 9, 2024 | Lawrence P. Guiheen Director | ADMA ADMA Biologics Inc | 9,000 | $146.3K | — | Sep 9, 2024 | — | Form 144 ↗ |
| Aug 30, 2024 | Kaitlin M. Kestenberg-Messina Officer | ADMA ADMA Biologics Inc | 24,150 | $415.9K | — | Aug 30, 2024 | — | Form 144 ↗ |
| Aug 29, 2024 | Jerrold B. Grossman Director | ADMA ADMA Biologics Inc | 136,861 | $2.4M | — | Aug 29, 2024 | — | Form 144 ↗ |
| Aug 26, 2024 | Adam S. Grossman Officer, Director | ADMA ADMA Biologics Inc | 626,245 | $11.4M | — | Aug 26, 2024 | Form 4 ↗ 88 days later · 48,967 shares | Form 144 ↗ |
| Jun 14, 2024 | Adam S. Grossman Officer, Director | ADMA ADMA Biologics Inc | 500,000 | $5.3M | 10b5-1 | Jun 14, 2024 | — | Form 144 ↗ |
| Mar 13, 2024 | Aisling Capital II LP Affiliate | ADMA ADMA Biologics Inc | 1.50M | $9.3M | — | Mar 13, 2024 | — | Form 144 ↗ |
| Aug 22, 2023 | Bryant Fong Board Member | ADMA ADMA Biologics Inc | 1.43M | $5.5M | — | Aug 22, 2023 | — | Form 144 ↗ |
| Aug 18, 2023 amended | Adam S. Grossman Officer - President and CEO | ADMA ADMA Biologics Inc | 2.12M | $9.5M | — | Aug 15, 2023 | — | Form 144/A ↗ |
| Aug 14, 2023 | Brian Lenz OFFICER-CFO | ADMA ADMA Biologics Inc | 1.02M | $4.6M | — | Aug 15, 2023 | — | Form 144 ↗ |
| Aug 14, 2023 | Adam S. Grossman Officer - President and CEO | ADMA ADMA Biologics Inc | 2.12M | $9.5M | — | Aug 15, 2023 | — | Form 144 ↗ |
25 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances